However, our analysis revealed a decreasing trend in both the number and relative share of publicly funded COVID-19 trials from 209 in April 2020 to 18 in August 2021, representing a decrease from 77.1% in April to 30.5% in August of all COVID-19 trials.
← all excerpts
Funding Sources of Therapeutic and Vaccine Clinical Trials for COVID-19 vs Non-COVID-19 Indications, 2020-2021.
1
—
—